Immunosuppression in sepsis.

Area of Science:

• Immunology
• Pathophysiology
• Critical Care Medicine

Background:

• Sepsis is a life-threatening condition driven by an imbalanced inflammatory response.
• The body's immune system, including innate and adaptive immunity, is profoundly affected by sepsis.
• Immune dysregulation in sepsis leads to impaired leukocyte function and increased mortality.

Purpose of the Study:

• To review the current literature on immune dysregulation during sepsis.
• To describe novel therapeutic strategies for augmenting host immunity in sepsis.

Main Methods:

• Literature review of studies on sepsis pathophysiology and immune responses.
• Analysis of functional defects in leukocytes from sepsis patients.
• Examination of therapeutic interventions targeting immune augmentation.

Main Results:

• Sepsis causes impaired leukocyte function, including reduced cell surface molecule expression, altered cytokine production, and accelerated apoptosis.
• A critical balance between pro- and anti-inflammatory mediators dictates sepsis-induced tissue injury.
• Evidence supports significant dysregulation of host immunity in sepsis syndrome.

Conclusions:

• Dysregulation of host immunity is a key feature of sepsis syndrome.
• Therapeutic interventions aimed at augmenting host immunity show promise for sepsis treatment.